Trial · NCT00368745
Results by group140
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 140
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Subjects at Endpoint (Post Alprazolam Free Week 6 or Last Observation Carried Forward [LOCF] Post Alprazolam Free Week 1) Who Are Benzodiazepine Free | Pregabalin 75 mg to 300 mg PO BID | 20 | participants | ||
| Number of Subjects at Endpoint (Post Alprazolam Free Week 6 or Last Observation Carried Forward [LOCF] Post Alprazolam Free Week 1) Who Are Benzodiazepine Free | Placebo 75 mg to 300 mg PO BID | 10 | participants | ||
| Mean Change From Baseline in Hamilton Anxiety Scale (HAM-A) Scores | Pregabalin 75 mg to 300 mg PO BID | Alprazolam Taper (AT) Week 1 (n=46, 40) | -0.82 | Standard Error 0.66 | scores on scale |
| Mean Change From Baseline in Hamilton Anxiety Scale (HAM-A) Scores | Placebo 75 mg to 300 mg PO BID | Alprazolam Taper (AT) Week 1 (n=46, 40) | 0.67 | Standard Error 0.81 | scores on scale |
| Mean Change From Baseline in Hamilton Anxiety Scale (HAM-A) Scores | Pregabalin 75 mg to 300 mg PO BID | AT Week 2 (n=45, 37) | -1.72 | Standard Error 0.98 | scores on scale |
| Mean Change From Baseline in Hamilton Anxiety Scale (HAM-A) Scores | Placebo 75 mg to 300 mg PO BID | AT Week 2 (n=45, 37) | 2.17 | Standard Error 1.15 | scores on scale |
| Mean Change From Baseline in Hamilton Anxiety Scale (HAM-A) Scores | Pregabalin 75 mg to 300 mg PO BID | AT Week 3 (n=33, 26) | -2.59 | Standard Error 0.99 | scores on scale |
| Mean Change From Baseline in Hamilton Anxiety Scale (HAM-A) Scores | Placebo 75 mg to 300 mg PO BID | AT Week 3 (n=33, 26) | -0.21 | Standard Error 1.32 | scores on scale |
| Mean Change From Baseline in Hamilton Anxiety Scale (HAM-A) Scores | Pregabalin 75 mg to 300 mg PO BID | AT Week 4 (n=18, 11) | -1.47 | Standard Error 1.11 | scores on scale |
| Mean Change From Baseline in Hamilton Anxiety Scale (HAM-A) Scores | Placebo 75 mg to 300 mg PO BID | AT Week 4 (n=18, 11) | 1.91 | Standard Error 1.82 | scores on scale |
| Mean Change From Baseline in Hamilton Anxiety Scale (HAM-A) Scores | Pregabalin 75 mg to 300 mg PO BID | AT Week 5 (n=8, 5) | -2.36 | Standard Error 2.19 | scores on scale |
| Mean Change From Baseline in Hamilton Anxiety Scale (HAM-A) Scores | Placebo 75 mg to 300 mg PO BID | AT Week 5 (n=8, 5) | 2.86 | Standard Error 2.97 | scores on scale |
| Mean Change From Baseline in Hamilton Anxiety Scale (HAM-A) Scores | Pregabalin 75 mg to 300 mg PO BID | AT Week 6 (n=17, 9) | -1.26 | Standard Error 1.40 | scores on scale |
| Mean Change From Baseline in Hamilton Anxiety Scale (HAM-A) Scores | Placebo 75 mg to 300 mg PO BID | AT Week 6 (n=17, 9) | 2.41 | Standard Error 2.11 | scores on scale |
| Mean Change From Baseline in Hamilton Anxiety Scale (HAM-A) Scores | Pregabalin 75 mg to 300 mg PO BID | Alprazolam Free (AF) Week 1 (n=39, 28) | -0.43 | Standard Error 0.90 | scores on scale |
| Mean Change From Baseline in Hamilton Anxiety Scale (HAM-A) Scores | Placebo 75 mg to 300 mg PO BID | Alprazolam Free (AF) Week 1 (n=39, 28) | 2.40 | Standard Error 1.15 | scores on scale |
| Mean Change From Baseline in Hamilton Anxiety Scale (HAM-A) Scores | Pregabalin 75 mg to 300 mg PO BID | AF Week 2 (n=35, 24) | -2.15 | Standard Error 0.91 | scores on scale |
| Mean Change From Baseline in Hamilton Anxiety Scale (HAM-A) Scores | Placebo 75 mg to 300 mg PO BID | AF Week 2 (n=35, 24) | -1.14 | Standard Error 1.19 | scores on scale |
| Mean Change From Baseline in Hamilton Anxiety Scale (HAM-A) Scores | Pregabalin 75 mg to 300 mg PO BID | AF Week 3 (n=31, 26) | -3.46 | Standard Error 0.92 | scores on scale |
| Mean Change From Baseline in Hamilton Anxiety Scale (HAM-A) Scores | Placebo 75 mg to 300 mg PO BID | AF Week 3 (n=31, 26) | -2.47 | Standard Error 1.14 | scores on scale |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00368745/results